Bellevue Life Sciences Acquisition (OSRH) Revenue (2022 - 2026)
Bellevue Life Sciences Acquisition (OSRH) revenue from Mar 31, 2022 to Mar 31, 2026. The TTM Bellevue Life Sciences Acquisition (OSRH) revenue is $2.63M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Bellevue Life Sciences Acquisition (OSRH) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -22.19% |
Annual Revenue change of Bellevue Life Sciences Acquisition (OSRH)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $480K | -83.51% |
| 2025 | $2.91M | -17.56% |
| 2024 | $3.53M | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |